160 related articles for article (PubMed ID: 12457721)
41. Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy.
Tan AR; Swain SM
Semin Oncol; 2002 Jun; 29(3 Suppl 11):77-85. PubMed ID: 12138401
[TBL] [Abstract][Full Text] [Related]
42. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
Li Y; Bhuiyan M; Alhasan S; Senderowicz AM; Sarkar FH
Clin Cancer Res; 2000 Jan; 6(1):223-9. PubMed ID: 10656453
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.
Jorda EG; Verdaguer E; Canudas AM; Jiménez A; Bruna A; Caelles C; Bravo R; Escubedo E; Pubill D; Camarasa J; Pallàs M; Camins A
Neuropharmacology; 2003 Oct; 45(5):672-83. PubMed ID: 12941380
[TBL] [Abstract][Full Text] [Related]
44. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development.
Zhai S; Senderowicz AM; Sausville EA; Figg WD
Ann Pharmacother; 2002 May; 36(5):905-11. PubMed ID: 11978170
[TBL] [Abstract][Full Text] [Related]
45. Flavopiridol as a radio-sensitizer for esophageal cancer cell lines.
Sato S; Kajiyama Y; Sugano M; Iwanuma Y; Tsurumaru M
Dis Esophagus; 2004; 17(4):338-44. PubMed ID: 15569374
[TBL] [Abstract][Full Text] [Related]
46. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
[TBL] [Abstract][Full Text] [Related]
47. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.
Puppo M; Pastorino S; Melillo G; Pezzolo A; Varesio L; Bosco MC
Clin Cancer Res; 2004 Dec; 10(24):8704-19. PubMed ID: 15623656
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of action of flavopiridol.
Sedlacek HH
Crit Rev Oncol Hematol; 2001 May; 38(2):139-70. PubMed ID: 11311660
[TBL] [Abstract][Full Text] [Related]
49. CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol.
Liu X; Shi S; Lam F; Pepper C; Fischer PM; Wang S
Int J Cancer; 2012 Mar; 130(5):1216-26. PubMed ID: 21484792
[TBL] [Abstract][Full Text] [Related]
50. Flavopiridol: pleiotropic biological effects enhance its anti-cancer activity.
Newcomb EW
Anticancer Drugs; 2004 Jun; 15(5):411-9. PubMed ID: 15166614
[TBL] [Abstract][Full Text] [Related]
51. Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol.
Pepper C; Thomas A; Hoy T; Tighe J; Culligan D; Fegan C; Bentley P
Cell Cycle; 2003; 2(1):53-8. PubMed ID: 12695689
[TBL] [Abstract][Full Text] [Related]
52. Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line.
Lee HR; Chang TH; Tebalt MJ; Senderowicz AM; Szabo E
Int J Oncol; 1999 Jul; 15(1):161-6. PubMed ID: 10375610
[TBL] [Abstract][Full Text] [Related]
53. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
54. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells.
Takada Y; Sethi G; Sung B; Aggarwal BB
Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248
[TBL] [Abstract][Full Text] [Related]
55. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
56. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.
Ruef J; Meshel AS; Hu Z; Horaist C; Ballinger CA; Thompson LJ; Subbarao VD; Dumont JA; Patterson C
Circulation; 1999 Aug; 100(6):659-65. PubMed ID: 10441105
[TBL] [Abstract][Full Text] [Related]
57. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
58. Antitumor effects of flavopiridol on human uterine leiomyoma in vitro and in a xenograft model.
Lee HG; Baek JW; Shin SJ; Kwon SH; Cha SD; Park WJ; Chung R; Choi ES; Lee GH; Cho CH
Reprod Sci; 2014 Sep; 21(9):1153-60. PubMed ID: 24572052
[TBL] [Abstract][Full Text] [Related]
59. A phenylacetate derivative, SCK6, inhibits cell proliferation via G1 cell cycle arrest and apoptosis.
Chan HC; Kuo SC; Huang LJ; Liu CH; Hsu SL
Eur J Pharmacol; 2003 Apr; 467(1-3):31-9. PubMed ID: 12706452
[TBL] [Abstract][Full Text] [Related]
60. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
